SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-24-000079
Filing Date
2024-06-17
Accepted
2024-06-17 17:18:14
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718659086.html 4  
1 FORM 4 wk-form4_1718659086.xml 4 5453
  Complete submission text file 0001439222-24-000079.txt   6938
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 241049293